biocon final
TRANSCRIPT
-
8/7/2019 Biocon final
1/21
KIRAN MAZUMDAR SHAW
THE BIOCON STORY
-
8/7/2019 Biocon final
2/21
Biocon Info.y Company's Slogan: Driving Innovation Delivering
Affordability
y
Company's Mission: To be an integrated biotechnologyenterprise of global distinction.
y Company Type: Private Sector
y Industry: Pharmaceuticals
y
Number of Employees -4478
-
8/7/2019 Biocon final
3/21
Dr. Kiran M. Shaw
Born on23 March
1953 inBangalor
e
B.ScZoology
fromBangalor
euniversity
1973
Masterbrewerfrom
BallaratUniversity
inMelbourne
1975
Traineebrewer inCarlton &
UnitedBeveragesin 1975-77
FirstIndianwoman
brewmaster
JoinedBiocon
biochemical Ltd.
Ireland in1978
Dr. KiranM. Shaw
In 1978foundedBioconIndia
-
8/7/2019 Biocon final
4/21
The journey beginsy Started Biocon India from her garage.
y Initial Capital Rs/- 10,000.
y Started extracting enzyme (papain) from papaya &isinglass (fish moss)
-
8/7/2019 Biocon final
5/21
Early Hurdlesy Financing regular operations
y Approached financial institutions, but turned down,
coz:y Biotechnology is a new word
y No assets for company
y Woman entrepreneur is a rare word
y
Recruiting staff
-
8/7/2019 Biocon final
6/21
Break through..y 1979 -Biocon is the first Indian company to manufacture
and export enzymes to USA and Europe
y 19 9-Unilever plc. acquires Biocon Biochemicals Ltd. inIreland and merges it with its subsidiary, QuestInternational
y Biocon is the first Indian biotech company to receive USfunding for proprietary technologies
y
1990 Biocon scales up its in-house research programme,based on a proprietary solid substrate fermentationtechnology, from pilot to plant level
y 1993 Biocon's R&D and manufacturing facilities receive ISO9001 certification from RWTUV, Germany
-
8/7/2019 Biocon final
7/21
Cont..y 1994 Biocon establishes Syngene International Pvt. Ltd. as a
Custom research Company (CRC) to address the growing needfor outsourced R&D in the pharmaceutical sector.Its India's first
custom research company in drug discovery.y 1997 Biocon spearheads initiatives in human healthcare througha dedicated manufacturing facility
y 199 Unilever inks a deal with ICI to sell its specialty chemicalsdivision of which Quest International is a part. Unilever agreesto sell its shareholding in Biocon to the Indian promoters.
Biocon becomes an independent entityy 2000 Biocon commissions its first fully automated submerged
fermentation plant to produce specialty pharmaceuticals.Bioconestablishes Clinigene, India's first Clinical ResearchOrganisation (CRO) to pursue clinical research anddevelopment
-
8/7/2019 Biocon final
8/21
Cont..y 2001 Biocon becomes the first Indian company to be approved by USFDA for the manufacture of lovastatin, a cholesterol-lowering moleculeBiocon's proprietary bioreactor, PlaFractor is granted a US 2001 andworld-wide patent
y 2002 Clinigene's clinical laboratory is the first in India to receive CAPaccreditation
y 2003 Biocon is the first company worldwide to develop human insulinon a Pichia expression system
y 2004 Biocon creates a buzz in the stock market in March 2004 with itshugely successful IPO. Day 1 on the bourses closes with a market valueof $1.11 billion, making Biocon only the second Indian company to crossthe $1 billion mark on the first day of listing.Biocon Limited announces the launch of INSUGENR, the newgeneration bio-insulin , manufactured in Asia's largest human insulinplant.
-
8/7/2019 Biocon final
9/21
-
8/7/2019 Biocon final
10/21
Cont..y 2006 Biocon inaugurates Biocon Biopharmaceuticals, India's
largest multi-product Biologics facility at Biocon ParkBiocon launches India's first anti-cancer drug BIOMAb EGFR.
y 2007 Biocon and Abu Dhabi based pharmaceutical companyNeopharma sign an MOU to establish a JV to manufacture andmarket a range of biopharmaceuticals for the GCC countries(Gulf Cooperation Council). .
y Biocon announces the launch of its Nephrology Division and acomprehensive portfolio of renal therapy products.
y 200 Biocon acquires a 70% stake in German pharmaceuticalcompany, AxiCorp GmbH for a consideration of 30 MillionBiocon and Abraxis Bioscience launch ABRAXANE in India for
treatment of Breast Cancer.
-
8/7/2019 Biocon final
11/21
Cont..y Biocon is ranked among the top 20 global
biotechnology companies (Med Ad News). Biocon is
the 7th largest biotech employer in the world (Med AdNews).
-
8/7/2019 Biocon final
12/21
The process
-
8/7/2019 Biocon final
13/21
Products and servicesBiopharmaceuticals icensing Contract manufacturing Research
services
Anti-Diabetic Agents Anti-Hypertensive Agents Anti-Inflammatory Agents Antioxidants Cardiovascular Agents
Digestive Aid Enzymes Haemostatic Agents Hepatoprotective Agents Immunosuppressants Nutraceuticals
-
8/7/2019 Biocon final
14/21
Financials
-
8/7/2019 Biocon final
15/21
Strategies
y No commodity production in beginning due to lack of infrastructurey Diversification rather than expansiony Formed Helix (antibiotic prod.)y Formed Syngene, Clinigene (R&D in fermentation)y Biocon Quest (BQ) to produce these products in massy Strategic alliances with 20 companies around globe. Eg AXICORP , DEAKIN
UNIVERSITYy Fully integrated business modely Enzymes produced & sold as industrial intermediariesy
Customer (staying with buyers processing line helping them obtain desiredresult from the enzyme)y Created an image of a reliable company able to give highly competent technical
products & supporty Also custom based products at any level.
-
8/7/2019 Biocon final
16/21
Competitors..y Cadila Healthcare
y Divi's Lab
y
Lupin Ltd.y Glenmark Pharma
y GlaxoSmithKline Phar
y Aurobindo Pharma
y Dr. Reddy's Labsy Fortis Healthcare
y Sun Pharma.
y Cipla (Sensex)
-
8/7/2019 Biocon final
17/21
Future & long term developmentsy Mega-marketing deal with
Pfizer to drive growth in theshort term:In October, 2010,
Biocon signed a mega-marketingdeal with the worlds largestPharma company.
y Focus on emerging countries
y Oral insulin the next
blockbuster opportunity
-
8/7/2019 Biocon final
18/21
CSR- Biocon
Foun
dation
y Arogya Raksha Yojana (ARY) Healthcare Initiatives
y Primary Health Education & Implementation
y Infrastructure: constructing school buildings(including a performance stage, ooring,classrooms),creches, sanitary facilities and watersupply connections.
Under phase I of the sanitation program, 700 toiletshave been built in Huskur.
-
8/7/2019 Biocon final
19/21
Recognition:y Kiran Mazumdar-Shaw features on the Forbes list of The
Worlds 100 Most Powerful Womeny Awarded the prestigious Nikkei Asia Prize 2009 for regional
growth.y Padma Bhushan (2005)y The Economic Times Business Woman of the Year Award (2004)y Ernst & Young Entrepreneur of the Year Award in Healthcare &
Life Sciences (2002) Padma Shri (1989)y Outstanding Young Person Award by Jaycees (1987) Rotary
award for the Best Model Employer (1983)y Gold for Best Woman Entrepreneur , Institute of Marketing
Management (1982)
-
8/7/2019 Biocon final
20/21
SUCCESS MANTRA MS. SHAWy Determination
y Willingness to take risk
y Talented teamy Spirit of Adventure
-
8/7/2019 Biocon final
21/21
Thank you.